Rates of Fentanyl Nonfatal Overdose ED Visits Rose Through Third Quarter of 2023

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 14, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 14, 2025 -- From 2020 to 2023, there was an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits, according to research published in the May 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Cassandra M. Pickens, Ph.D., from the CDC in Atlanta, and colleagues analyzed quarterly trends in rates of suspected nonfatal overdose of unintentional or undetermined intent involving fentanyl or fentanyl analogs overall and by age group, sex, and race and ethnicity.

The researchers found an increase in the rates of fentanyl-involved nonfatal overdose emergency department visits of 8.7 percent per quarter during quarter (Q) 4 of 2020 to Q3 of 2023, from 1.4 to 3.5 per 10,000 emergency department visits, followed by an 11.0 percent decrease per quarter from Q3 of 2023 to Q1 of 2024, to 2.9 per 10,000 emergency department visits. Through mid-2023, trends increased among a majority of demographic groups; non-Hispanic American Indian or Alaska Native persons had the highest rates and the largest increases (e.g., 11.9 per 10,000 emergency department visits in Q3 of 2023 and an average quarterly increase of 9.0 percent).

"Ongoing monitoring of trends in fentanyl-involved nonfatal overdoses by state and local jurisdictions can identify areas in need of evidence-based prevention, treatment, and recovery support services," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-15 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords